TrialJournal of the American College of Cardiology2022

Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.

Paul Lacaze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.